Archives of pathology & laboratory medicine
June 12, 2026 Β· via Europe PMC
Intracholecystic Tubular Nonmucinous Neoplasm of the Gallbladder.
Pehlivanoglu B.
AI summary β for doctors, generated from the abstract only
This review describes intracholecystic tubular nonmucinous neoplasm (ICTN), a recently recognized, distinct type of gallbladder polyp that behaves differently from other intracholecystic neoplasms and has not been documented to develop invasive carcinoma to date.
What was studied
A literature-based review of the clinicopathologic characteristics of intracholecystic tubular nonmucinous neoplasm (ICTN) of the gallbladder, a recently described subcategory of intracholecystic neoplasms, drawing on published literature and the author's own research.
Key findings
- ICTNs typically present as solitary pedunculated polyps (sometimes appearing as detached luminal debris) arising in a background of otherwise uninvolved gallbladder, unlike ordinary intracholecystic papillary neoplasms which can be diffuse and multifocal.
- ICTNs appear to arise from cholesterol polyps and resemble pancreatic/biliary intraductal tubulopapillary neoplasms by morphology and MUC6 expression; they have also been called "complex nonmucinous pyloric gland adenomas."
- Despite warranting a diagnosis of high-grade dysplasia/carcinoma in situ (and being called "tubular adenocarcinoma" in some regions), no documented invasive carcinoma has developed from ICTN to date.
- The presence of morules with nuclear beta-catenin expression places ICTN in the BROCN family of tumors, believed to be hormonally driven.
Clinical relevance
This review may be relevant to pathologists for recognizing ICTN as a distinct, apparently indolent entity that should be distinguished from other intracholecystic neoplasms with higher field risk, potentially affecting how such lesions are classified and managed, though further molecular studies are needed to confirm its biological behavior.
Who should care
Limitations
As a review article, it does not present original patient outcome data with statistical analysis; conclusions about invasion resistance are based on the absence of documented invasive cases reported to date in the literature rather than a prospective outcomes study.
Intracholecystic tubular nonmucinous neoplasm is a distinct, apparently invasion-resistant gallbladder polyp type that should be differentiated from other intracholecystic neoplasms.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates β verify against the original source before acting on it.
Abstract
Context.β
Intracholecystic neoplasms (ICNs) of gallbladder are a challenging and relatively poorly understood family of tumors. Recently, a distinct category of ICNs, characterized by pedunculated polyps composed of lobules of back-to-back small tubular/acinar units lined by minimally mucinous or nonmucinous cells, has been found to be biologically, behaviorally, and molecularly different from other ICNs, and termed intracholecystic tubular nonmucinous neoplasm (ICTN).
Objective.β
To review the clinicopathologic characteristics of ICTN of the gallbladder.
Data sources.β
This review is based on the literature and the author's own research.
Conclusions.β
ICTNs, initially recognized by their distinctive morphology and growth pattern, have distinct clinicopathologic characteristics. They are unlikely to be diffuse and multifocal like ordinary intracholecystic papillary neoplasms (ICPNs), and they do not appear to confer the field risk that ICPNs do. Instead, they form solitary pedunculated polyps (and often appear as detached debris in the lumen) and occur in the background of uninvolved gallbladder. In fact, they appear to be arising in cholesterol polyps. By morphology and MUC6 expression they resemble pancreatic/biliary intraductal tubulopapillary neoplasms, and they have been also called "complex nonmucinous pyloric gland adenomas" in the past. Although their complexity warrants the diagnosis of high-grade dysplasia/carcinoma in situ (and they have been typically diagnosed as "tubular adenocarcinoma" in Asia and South America), ICTNs are invasion resistant, with no documented invasive carcinoma developing within this lesion to date. The presence of morules, which display nuclear Ξ²-catenin expression, places this lesion in the so-called BROCN family of tumors, which are believed to be hormonally driven. Further molecular studies are needed to explore the roots of their behavior.
DOI
10.5858/arpa.2025-0522-ra
PMID
42307525
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed